broggini massimo
机构: Istituto Mario Negri
每年引用次数
引用次数
引用: 12,180
H-指数: 63
I10-指数 : 195
出版物: 401
Silver Ions as a Tool for Understanding Different Aspects of Copper Metabolism.
Ludmila V Puchkova , Massimo Broggini , Elena V Polishchuk , Ekaterina Y Ilyechova
Nutrients 11 ( 6) 1364
13
2019
Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.
Fabiana Caporuscio , Annachiara Tinivella , Valentina Restelli , Marta S Semrau
Future Medicinal Chemistry 10 ( 13) 1545 -1553
6
2018
Development of distamycin-related DNA binding anticancer drugs
Sergio Marchini , Massimo Broggini , Cristiana Sessa , Maurizio D’Incalci
Expert Opinion on Investigational Drugs 10 ( 9) 1703 -1714
39
2001
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines
Sarah Franco Vieira de Oliveira , Monica Ganzinelli , Rosaria Chilà , Leandro Serino
PLOS ONE 11 ( 1) e0145647 --
25
2016
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
Marianna Macerelli , Monica Ganzinelli , Cedric Gouedard , Massimo Broggini
Cancer Treatment Reviews 48 8 -19
19
2016
Abstract LB-245: Multiple DNA-damage response pathways are modulated by RANBP9 protein in NSCLC
Anna Tessari , Kareesma Parbhoo , Meghan Pawlikowski , Matteo Fassan
Cancer Research 78
2018
Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.
Laura Brunelli , Elisa Caiola , Mirko Marabese , Massimo Broggini
Scientific Reports 6 ( 1) 28398 -28398
19
2016
Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function
Ugo De Giorgi , Juping Yuan , Mauro Moroni , Silvio Veronese
International Journal of Biological Markers 30 ( 3) 275 -281
2015
Establishment of l1210 leukemia cells resistant to the distamycin-a derivative (FCE 24517): Characterization and cross-resistance studies
Cristina Geroni , Enrico Pesenti , Giovanna Tagliabue , Dario Ballinari
International Journal of Cancer 53 ( 2) 308 -314
17
1993
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors
Elisa Caiola , Alice Iezzi , Michele Tomanelli , Elisa Bonaldi
Journal of Thoracic Oncology 15 ( 3) 360 -370
10
2020
LKB1ness Dictates ERK Inhibitors Response in NSCLC.
Elisa Caiola , Massimo Broggini , Mirko Marabese
Journal of Thoracic Oncology 15 ( 4)
1
2020
Brassinin and its derivatives as potential anticancer agents.
Martina Chripkova , David Drutovic , Martina Pilatova , Jaromir Mikes
Toxicology in Vitro 28 ( 5) 909 -915
20
2014
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
Elisa Caiola , Roberta Frapolli , Michele Tomanelli , Rossana Valerio
Scientific Reports 8 ( 1) 948
2018
Non-hepatic tumors change the activity of genes encoding copper trafficking proteins in the liver
Polina S Babich , Alexey N Skvortsov , Paolo Rusconi , Nadezhda V Tsymbalenko
Cancer Biology & Therapy 14 ( 7) 614 -624
9
2013
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
Chiara Tarantelli , Eugenio Gaudio , Alberto J Arribas , Ivo Kwee
Clinical Cancer Research 24 ( 1) 120 -129
35
2018
Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS
Elisa Caiola , Laura Brunelli , Mirko Marabese , Massimo Broggini
Oncotarget 7 ( 32) 51462 -51472
11
2016
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
Anissa Chikh , Riccardo Ferro , Jonathan J Abbott , Roberto Piñeiro
Oncotarget 7 ( 14) 18325 -18345
14
2016
DNA Damage Induces p53-dependent Down-regulation of hCHK1
Giovanna Damia , Yolanda Sanchez , Eugenio Erba , Massimo Broggini
Journal of Biological Chemistry 276 ( 14) 10641 -10645
16
2001
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
Martina Imbimbo , Milena Vitali , Alessandra Fabbri , Margaret Ottaviano
Clinical Lung Cancer 19 ( 5)
6
2018
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.
Claudio Vernieri , Diego Signorelli , Giulia Galli , Monica Ganzinelli
Clinical Lung Cancer 20 ( 3)
26
2019